Cite
Effectiveness of the PPARγ agonist, GW570, in liver fibrosis.
MLA
Yang, Liu, et al. “Effectiveness of the PPARγ Agonist, GW570, in Liver Fibrosis.” Inflammation Research, vol. 59, no. 12, Dec. 2010, pp. 1061–71. EBSCOhost, https://doi.org/10.1007/s00011-010-0226-0.
APA
Yang, L., Stimpson, S., Chen, L., Wallace Harrington, W., & Rockey, D. (2010). Effectiveness of the PPARγ agonist, GW570, in liver fibrosis. Inflammation Research, 59(12), 1061–1071. https://doi.org/10.1007/s00011-010-0226-0
Chicago
Yang, Liu, Stephen Stimpson, Lihong Chen, W. Wallace Harrington, and Don Rockey. 2010. “Effectiveness of the PPARγ Agonist, GW570, in Liver Fibrosis.” Inflammation Research 59 (12): 1061–71. doi:10.1007/s00011-010-0226-0.